Blumendeller, C., Boehme, J., Frick, M., Schulze, M., Rinckleb, A., Kyzirakos, C., Kayser, S., Kopp, M., Kelkenberg, S., Pieper, N., Bartsch, O., Hadaschick, D., Battke, F., Stenzl, A., & Biskup, S. (2021). use of plasma ctDNA as a potential biomarker for longitudinal monitoring of a patient with metastatic high-risk upper tract urothelial carcinoma receiving pembrolizumab and personalized neoepitope-derived multipeptide vaccinations: a case report. Journal for immunotherapy of cancer, 9(1), . http://access.bl.uk/ark:/81055/vdc_100127565653.0x000033